13.07.20 ijBio Portfolio

13.07.20 ijBio Portfolio

Infojet Club

Pharm Involved.

$1,000,000 on 12.06.20 Changes for 13.07.20:

AstraZeneca (AZN) $51,3 $53,2 (+3.7%) $103,700

Inovio (INO) $13,2 $25,6 (+93.9%) $193,300

Moderna (MRNA)$61,5 $71,8 (+16.7%) $116,700

Abbot (ABT) $88,5 $93 (+5%) $105,000

Gilead (GILD) $72,5.  $76,7 (+5.8%) $105,800

Adaptive (ADPT) $42,2.  $44,2 (+4.7%) $104,700

CytoDyn (CYDY) $3,12 $3,7 (+18.5%) $118,500

AbbVie (ABBV) $92,2 $97,9 (+6.2%) $106,200

Arcus (RCUS) $27,3 $22,6 (-17.2%) $82,800

Sorrento (SRNE) $4,6  $7,72 (+67,8%) $167,800

At close 13.07.20= $ 1,204,500 (-1,6%)

per million dollars at 10% per share.


previous day

At close 10.07.20= $ 1,224,200

during the week 03-10.06.2020: +0.5%

At close 02.07.20= $1,220,500

during the week 26-03.06.2020: -4.5%

At close 26.06.20= $1,279,600

during the week 19-26.06.2020:+21%

At close 19.06.20= $1,057,700

during the week 12-19.06 +5,5%

12.06.20 = $1,000,000

Global Communication Platforms portfoilio

--

Portfolio News:

Abbott Laboratories and Edwards Lifesciences Settle Patent Fight

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE

Roche Forecasted to Be Top Drug Seller in 2026

Dow Up 933 Points In 2 Days, But Pulls Back Late; Why Moderna Hit A New Buy Point

Gilead Sciences (GILD) Gains As Market Dips: What You Should Know

Abbott Labs, Edwards Lifesciences settle patent dispute over heart valve products

Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences

Gilead Sciences and Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies

Why Moderna Stock Surged Today

Gilead Sciences Is Set to Break Out: How to Play It

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of R, SRNE and WFC

SRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Sorrento Therapeutics, Inc and Encourages Investors With Losses Exceeding $250K to Contact the Firm


Infojet Club

With help but without the assistance of Yahoo Finance

Advertise With Us











Report Page